0000919574-15-005180.txt : 20150702
0000919574-15-005180.hdr.sgml : 20150702
20150702131750
ACCESSION NUMBER: 0000919574-15-005180
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150630
FILED AS OF DATE: 20150702
DATE AS OF CHANGE: 20150702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP
CENTRAL INDEX KEY: 0001157601
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-274-8200
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kovner Bruce
CENTRAL INDEX KEY: 0001325713
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33277
FILM NUMBER: 15968433
MAIL ADDRESS:
STREET 1: C/O CAXTON ASSOCIATES
STREET 2: 500 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
p6680514.xml
BRUCE/SYNTA
X0306
4
2015-06-30
0
0001157601
SYNTA PHARMACEUTICALS CORP
SNTA
0001325713
Kovner Bruce
C/O CAXTON CORPORATION
731 ALEXANDER ROAD, BLDG. 2
PRINCETON
NJ
08540
1
0
1
0
Common Stock
2015-06-30
4
J
0
2279146
A
2279146
I
By wife
Common Stock
2015-06-30
4
J
0
250000
D
0
I
By Kovner 2011 Family Trust
Common Stock
2015-06-30
4
J
0
125000
D
0
I
By Kovner 2011-C Investment Trust
Common Stock
2015-06-30
4
J
0
125000
D
0
I
By Kovner 2011-D Investment Trust
Common Stock
2015-06-30
4
J
0
475000
D
0
I
By Kovner 2012 Family Trust A
Common Stock
2015-06-30
4
J
0
475000
D
0
I
By Kovner 2012-B Synta Investment Trust
Common Stock
2015-06-30
4
J
0
475000
D
0
I
By Kovner 2012-C Synta Investment Trust
Common Stock
2015-06-30
4
J
0
354146
D
120854
I
By Kovner 2012-D Synta Investment Trust
Common Stock
2015-07-01
4
A
0
22727
A
3083587
D
Common Stock
2015-07-01
4
A
0
4545
A
3088132
D
Common Stock
2015-07-01
4
A
0
4545
A
3092677
D
Common Stock
15278610
I
By KFO Holdings LLC
Common Stock
5460000
I
By OB Select Opportunities, LLC
Common Stock
7761716
I
By CxSynta LLC
Common Stock
3100000
I
By Kovner 2012 Family Trust B
Director Stock Option (Right to Buy)
2.20
2015-07-01
4
A
0
20000
0
A
2025-07-01
Common Stock
20000
20000
D
Reflects the transfer of a total of 2,279,146 shares from the Kovner 2011 Family Trust, Kovner 2011-C Investment Trust, Kovner 2011-D Investment Trust, Kovner 2012 Family Trust A, Kovner 2012-B Synta Investment Trust, Kovner 2012-C Synta Investment Trust, and Kovner 2012-D Synta Investment Trust to the wife of the Reporting Person.
These securities are owned by the wife of the Reporting Person.
These shares are owned directly by KFO Holdings LLC ("KFO") and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the manager of KFO. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
These shares are owned directly by OB Select Opportunities, LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the manager of OB Select Opportunities, LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
These shares are owned directly by CxSynta LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the managing member of CxSynta LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date.
Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a member of the Compensation Committee of the Board of Directors of the Issuer on such date.
Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a member of the Nominating and Governance Committee of the Board of Directors of the Issuer on such date.
The option vests as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date.
/s/ Heath N. Weisberg, Attorney-In-Fact
2015-07-02